The Latest Breaking News from Vaccine

Fainting and fatigue may signal onset of variant, experts say

The three-time champion at Flushing Meadows is forbidden from entering the US. Many conservatives have used him to push their agenda

The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.

The United States should replace most of its COVID-19 booster shots with updated versions that target the dominant omicron strains, an influential group of vaccine experts that advises the Centers for Disease Control and Prevention said Thursday.

Moderna’s shot will be available to adults 18 and older, and Pfizer’s will be available to individuals 12 and older.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

A jump in the number of deaths among children in Europe could be caused by numerous factors, experts said, but vaccines are not to blame.

CERVAVAC, India’s first indigenously developed vaccine to prevent cervical cancer, has been developed by SII

“We very much are going to want people to get this updated vaccine right now and not wait three or four months,” she said.

Germany can next week start using COVID-19 vaccines which have been adapted for the Omicron variant and got approval for use in the European Union on Thursday, Health Minister Karl Lauterbach said.